Exercise Training for Cardiovascular Disease
(CIED-EX Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores new methods to help women with cardiac implantable electronic devices (CIED) enhance their fitness and quality of life. It compares two exercise programs: high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT), both conducted virtually. The researchers aim to determine which program more effectively improves physical health, anxiety levels, and overall well-being. Women who have had a CIED for at least six months, are not currently exercising regularly, and have internet access may be suitable candidates for this trial. As an unphased trial, it offers participants the chance to contribute to innovative research that could improve fitness strategies for women with CIEDs.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. It mentions that participants should be on optimal medical therapy, which suggests you may need to continue your current medications.
What prior data suggests that these exercise programs are safe for women with CIED?
Research has shown that high-intensity interval training (HIIT) is generally safe for individuals with heart conditions like coronary artery disease and heart failure. Studies have found that serious heart-related problems rarely occur during HIIT exercises. Additionally, HIIT can enhance heart fitness and overall health.
Moderate-intensity continuous exercise training (MICT) is also well-tolerated. Research comparing HIIT and MICT indicates that both exercise types have similar positive effects on the quality of life and mental health of those with heart conditions. This suggests that MICT, which involves exercising at a steady pace, is safe for individuals with heart issues.
Both exercise methods are considered safe and beneficial for improving heart health, making them good options for people with heart conditions.12345Why are researchers excited about this trial?
Researchers are excited about these exercise programs for cardiovascular disease because they offer a fresh approach to managing the condition through virtual platforms. Unlike traditional exercise regimens that might require in-person attendance, these treatments use Zoom Care to provide supervised sessions remotely, making them more accessible to participants. High-intensity interval training (HIIT) is particularly promising as it alternates between short bursts of intense activity and rest, potentially improving heart health more efficiently than continuous moderate exercise. Meanwhile, moderate-intensity continuous exercise training (MICT) provides a steady, manageable workout that can be sustained over time, offering flexibility and consistency without needing to visit a physical location.
What evidence suggests that this trial's treatments could be effective for women with CIED?
Research has shown that high-intensity interval training (HIIT), one of the treatments in this trial, can greatly improve heart health. It enhances exercise capacity, reduces the risk of heart problems, and improves the quality of life for individuals with heart conditions. In many cases, HIIT boosts fitness levels more effectively than moderate-intensity continuous training (MICT), another treatment option in this trial. MICT also lowers the risk of heart disease and improves overall fitness. Both HIIT and MICT can enhance quality of life and mental health, but HIIT often results in greater fitness improvements.12367
Who Is on the Research Team?
Jennifer Reed, PhD
Principal Investigator
Ottawa Heart Institute Research Corporation
Are You a Good Fit for This Trial?
This trial is for women with cardiac devices (CIED) who've had them for at least 6 months, can read English or French, and are able to do a CPET exercise test. They should be on optimal medical therapy and not already doing regular exercise more than twice a week. Women who are pregnant or without internet cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a 12-week virtual exercise program with either HIIT or MICT, conducted twice a week via Zoom.
Follow-up
Participants are monitored for safety and effectiveness after the exercise intervention, including assessments of cardiometabolic health indicators and mental health.
What Are the Treatments Tested in This Trial?
Interventions
- High-intensity interval training (HIIT)
- Moderate-intensity continuous exercise training (MICT)
High-intensity interval training (HIIT) is already approved in European Union, United States for the following indications:
- Cardiovascular rehabilitation
- Improvement of peak oxygen uptake (VO2 peak)
- Enhancement of physical functioning and quality of life
- Cardiovascular rehabilitation
- Improvement of peak oxygen uptake (VO2 peak)
- Enhancement of physical functioning and quality of life
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ottawa Heart Institute Research Corporation
Lead Sponsor